Certara, Inc. Common Stock (CERT) Stock
NASDAQ · CERT
Key stats
- Market cap
- $1.79B
- Price / Earnings ratio
- -28.7x
- EPS (TTM)
- -$0.42
- Volume
- Loading
- 52-week high
- $12.61
- 52-week low
- $4.45
Source: third-party data provider, as of November 13, 2026
Compare with CERT
Recent news

MarketBeat
Certara Q2 Earnings Call Highlights
CERTAugust 4, 2026
MarketBeat
Certara Q2 Earnings Call Highlights
CERT

Zacks Investment Research
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
CERTAugust 4, 2026
Zacks Investment Research
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
CERT

MarketBeat
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
CERTJune 7, 2026
MarketBeat
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
CERT

Business Wire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CERTMay 20, 2026
Business Wire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CERT
Technical indicators
- RSI 14
- 63.78
- MACD 12/26/9
- 0.72
- EMA 9 of MACD
- 0.65
- MACD histogram
- 0.07
- SMA 50
- $9.56
- Price above SMA 50
- EMA 50
- $9.89
- Price above EMA 50
- SMA 200
- $7.34
- Price above SMA 200
- EMA 200
- $8.22
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 4 analyst ratings
Strong Sell0
Sell0
Hold2
Buy2
Strong Buy0
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
503M332M166M0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
2B1B624M0
Revenue to Profit
2025$418.8M
Revenue$0.0
Cost of revenue$257.7M
Gross profit$0.0
Operating expenses$-1.6M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

MarketBeat
Certara Q2 Earnings Call Highlights
CERTAugust 4, 2026
MarketBeat
Certara Q2 Earnings Call Highlights
CERT

Zacks Investment Research
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
CERTAugust 4, 2026
Zacks Investment Research
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
CERT

MarketBeat
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
CERTJune 7, 2026
MarketBeat
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
CERT

Business Wire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CERTMay 20, 2026
Business Wire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
CERT

Business Wire
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
CERTMay 13, 2026
Business Wire
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
CERT

MarketBeat
Certara Q1 Earnings Call Highlights
CERTMay 11, 2026
MarketBeat
Certara Q1 Earnings Call Highlights
CERT

Zacks Investment Research
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
CERTMay 11, 2026
Zacks Investment Research
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
CERT

Business Wire
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
CERTMay 7, 2026
Business Wire
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
CERT

Business Wire
Veristat to Acquire Certara's Regulatory and Medical Writing Business
CERTApril 22, 2026
Business Wire
Veristat to Acquire Certara's Regulatory and Medical Writing Business
CERT

Zacks Investment Research
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
CERTFebruary 26, 2026
Zacks Investment Research
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
CERT
About Certara, Inc. Common Stock
No description available.
SectorHealthcare
IndustryHealth Information Services
Employees1,515
CEOMr. Jon Resnick
IPO DateDec 9, 2020
HeadquartersRadnor, PA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon Resnick | CEO & Director | 1973 |
| Mr. Faiz Mohammed | Interim CFO, Senior VP of Finance, Treasurer and Principal Financial & Accounting Officer | 1973 |
| Dr. Robert P. Aspbury Ph.D. | President of Certara Predictive Technologies | 1972 |
| Mr. Leif E. Pedersen | Senior Advisor | 1965 |
| Dr. Adrian K. McKemey Ph.D. | President of Drug Development Solutions | — |
| Mr. Julien Perrier | President & Chief Commercial Officer | — |
| Dr. Christopher Bouton Ph.D. | Chief Technology Officer & Chief AI Officer | — |
| Eric Jahn | Chief Information Officer | — |
| Mr. Daniel D. Corcoran | Senior VP, General Counsel & Secretary | 1967 |
| Mr. Ron DiSantis | Senior Vice President of Corporate Development | — |
Fundamentals
Valuation
Price-to-sales ratio4.70
Price-to-book value1.89
Profitability
Return on Equity-6.00%
Return on Assets-4.00%
Return on Sales-10.00%
Gross margin (latest quarter)66.87%
EBITDA$29.41M
Trading
Average volume2,549,865
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 63.78
- MACD 12/26/9
- 0.72
- EMA 9 of MACD
- 0.65
- MACD histogram
- 0.07
- SMA 50
- $9.56
- Price above SMA 50
- EMA 50
- $9.89
- Price above EMA 50
- SMA 200
- $7.34
- Price above SMA 200
- EMA 200
- $8.22
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Analyst consensus:Hold
50% Buy
50% Hold
0% Sell
Analyst price target
- Low
- $10.00
- Average
- $11.25
- High
- $12.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -29.2 | +6.6 | ||||||||||
| 2022 | -7.0 | -5.2 | -12.9 | -17.5 | +5.9 | +11.0 | +4.1 | -31.9 | -14.4 | -8.7 | +35.9 | -6.7 |
| 2023 | +19.5 | -7.9 | +30.7 | +2.5 | -15.7 | -14.5 | +5.9 | -15.4 | -11.8 | -15.3 | +16.7 | +20.2 |
| 2024 | -6.9 | +1.9 | -2.3 | -4.9 | -2.0 | -20.3 | +14.4 | -21.7 | -0.8 | -10.1 | +9.4 | -5.7 |
| 2025 | +33.5 | -14.3 | -17.1 | +40.4 | -14.5 | +6.4 | -14.6 | +13.6 | +14.6 | -13.0 | -21.7 | -0.5 |
| 2026 | +0.6 | -14.7 | -19.1 | +11.5 | -5.8 | +7.0 | +20.4 | +1.3 | +13.6 | +18.0 | +9.5 |
Compare stocks
Market cap
$1.79B
-
-
-
Price / Earnings ratio
-28.70
-
-
-
Price / Sales ratio
4.70
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
2,549,865
-
-
-
Earnings per share
$-0.42
-
-
-



